BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24035795)

  • 1. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
    Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B
    Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome?
    Campos LM; Omori CH; Lotito AP; Jesus AA; Porta G; Silva CA
    Lupus; 2010 Dec; 19(14):1654-8. PubMed ID: 20837568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe and life-threatening onset of systemic lupus erythematosus.
    Martins A; Pimenta S; Oliveira D; Martins F; Samões B; Costa L
    Reumatol Clin (Engl Ed); 2023; 19(7):402-403. PubMed ID: 37661117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
    Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
    J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
    Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
    Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic syndrome as the initial manifestation of systemic lupus erythematosus.
    Egües Dubuc CA; Uriarte Ecenarro M; Meneses Villalba C; Aldasoro Cáceres V; Hernando Rubio I; Belzunegui Otano J
    Reumatol Clin; 2014; 10(5):321-4. PubMed ID: 24316336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report.
    Fioravante da Silveira L; Zago A; Zanchet D; Chemello D
    Reumatismo; 2023 Jul; 75(2):. PubMed ID: 37462126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
    Tulbă D; Balea M; Băicuş C
    Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
    Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
    Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
    Jiang N; Li MT; Wu D; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute lupus hemophagocytic syndrome: report of a case.
    Botelho C; Ferrer F; Francisco L; Maia P; Mendes T; Carreira A
    Nefrologia; 2010; 30(2):247-51. PubMed ID: 20038974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation syndrome triggered by active systemic lupus erythematosus : Successful treatment by interleukin-1 inhibition (anakinra).
    Kübler L; Bittmann I; Kuipers JG
    Z Rheumatol; 2020 Dec; 79(10):1040-1045. PubMed ID: 32804304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.
    Bennett TD; Fluchel M; Hersh AO; Hayward KN; Hersh AL; Brogan TV; Srivastava R; Stone BL; Korgenski EK; Mundorff MB; Casper TC; Bratton SL
    Arthritis Rheum; 2012 Dec; 64(12):4135-42. PubMed ID: 22886474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
    Aoyama-Maeda N; Horino T; Ichii O; Terada Y
    Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.
    Bakshi J; Hassan S; D'Cruz D; Chan A
    Lupus; 2013 Dec; 22(14):1544-6. PubMed ID: 24014570
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.
    Gavand PE; Serio I; Arnaud L; Costedoat-Chalumeau N; Carvelli J; Dossier A; Hinschberger O; Mouthon L; Le Guern V; Korganow AS; Poindron V; Gourguechon C; Lavigne C; Maurier F; Labro G; Heymonet M; Artifoni M; Viau AB; Deligny C; Sene T; Terriou L; Sibilia J; Mathian A; Bloch-Queyrat C; Larroche C; Amoura Z; Martin T
    Autoimmun Rev; 2017 Jul; 16(7):743-749. PubMed ID: 28483541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.
    Junga Z; Stitt R; Tracy C; Keith M
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28827301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemophagocytic Syndrome: a clinical presentation of systemic lupus erythematosus].
    Silva Dda F; Anunciação FA; Arcoverde Jda C; Costa LP; Marques ID; Pinheiro Gda S; Moreira Mdo S
    Acta Reumatol Port; 2008; 33(1):91-7. PubMed ID: 18344927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of macrophage activation syndrome in children with rheumatic disorders.
    Moradinejad MH; Ziaee V
    Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus.
    Tochihara M; Kasai M; Katsumata Y; Sato E; Ishiguro N; Kazama H; Sugimoto N; Ichida H; Kawaguchi Y; Yamanaka H
    Mod Rheumatol; 2016 Nov; 26(6):956-957. PubMed ID: 25036234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.